These included two pathways with established roles in AKI [28,29]: the glycoprotein VI (GP6) signalling pathway (pro-inflammatory, activated between Baseline and ADHF), and the acute phase response signalling pathway (pro-inflammatory, inhibited between ADHF and Recovery). This evidence concerns the gene GP6 and acute kidney injury.